Trade Pfizer ^PFE

Best Dividend Stocks To Follow Today - December 15th - Markets Daily

Promising Pharmaceutical Stocks To Watch Now - December 15th - Markets Daily

Watts Gwilliam & Co. LLC Buys 50,744 Shares of Pfizer Inc. $PFE

Bank of America Lowers Pfizer (NYSE:PFE) Price Target to $28.00

ANALYSIS: Novo's Novel GLP-1 Bid Failed But That's Not the Point

MASTERINVEST Kapitalanlage GmbH Makes New Investment in Pfizer Inc. $PFE - Markets Daily

47,996 Shares in Pfizer Inc. $PFE Acquired by MASTERINVEST Kapitalanlage GmbH

FDA approves Pfizer's RSV vaccine for pregnant women amid safety concerns and growing vaccine debate - NaturalNews.com

Pfizer Inc. $PFE Shares Sold by SevenBridge Financial Group LLC - Stock Observer

Watts Gwilliam & Co. LLC Has $1.92 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political

Top Dividend Stocks To Follow Now - December 14th - Markets Daily

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?

MRP Capital Investments LLC Has $494,000 Stock Holdings in Pfizer Inc. $PFE - Markets Daily

Beddow Capital Management Inc. Cuts Stock Holdings in Pfizer Inc. $PFE

Banque Transatlantique SA Lowers Stake in Pfizer Inc. $PFE

Bellevue Group AG Reduces Holdings in Pfizer Inc. $PFE - Markets Daily

Pfizer Inc. $PFE Shares Purchased by Adage Capital Partners GP L.L.C.

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer

Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study

Dividend Stocks To Follow Now - December 12th - Markets Daily

Healthy Returns: FDA may add strongest safety warning to Covid shots

Pfizer Stock (PFE) Gets Cautious 2026 Call from Morgan Stanley - Here's Why | Markets Insider

Pfizer Inc. $PFE Shares Sold by Camber Capital Management LP - Markets Daily

FDA intends to put its most serious warning on Covid vaccines, sources say | CNN

Camber Capital Management LP Has $36.36 Million Stock Holdings in Pfizer Inc. $PFE - Stock Observer

RFK Jr.'s Former Group Urges FDA to Revoke COVID Vax Licenses | MedPage Today

Why AbbVie, Pfizer and Medtronic appeal to dividend investors

Democratic Senators Demand Details on Trump's Drugmaker Deals

Pharma deal a near-total victory for industry lobbying effort

Town Health donates Pfizer pneumococcal vaccines PCV20, as chair Karson Choi urges seniors to get vaccinated

Top Pharmaceutical Stocks To Keep An Eye On - December 11th - Daily Political

Pfizer Inc. (PFE) Announces Results from Phase 3 BASIS Study

Will Obesity Bet and TUKYSA Data Shift Pfizer's (PFE) Post-COVID Growth Narrative?

Pfizer Inc. $PFE Shares Sold by Marshall Wace LLP

How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating

Pfizer Inc. $PFE Shares Sold by Schwerin Boyle Capital Management Inc. - Daily Political

FDA investigating possible adult deaths from COVID vaccines - San Diego Union-Tribune

Pfizer (NYSE:PFE) Trading Up 1.7% - Here's Why - Stock Observer

'Misbranded': Petition urges delicensing of COVID shots over failure to comply with rules * WorldNetDaily * by Bob Unruh

Pfizer layoffs: Pharma giant to cut hundreds of jobs in this country to reduce costs

Pfizer to cut over 200 jobs in Switzerland to reduce costs, Bloomberg News reports

Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI

Fosun"s Yao Pharma, Pfizer sign exclusive collaboration deal

Pfizer Inc. $PFE Shares Sold by Lombard Odier Asset Management Switzerland SA

Pfizer Inc. $PFE Shares Bought by Daiwa Securities Group Inc. - Markets Daily

Axa S.A. Raises Stock Holdings in Pfizer Inc. $PFE

Arrow Capital Pty Ltd Acquires New Shares in Pfizer Inc. $PFE

Lombard Odier Asset Management Switzerland SA Cuts Holdings in Pfizer Inc. $PFE - Stock Observer

China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China Morning Post

Pfizer Weight-loss Pill: Pfizer to License YaoPharma's $2 Billion Weight-Loss Pill YP05002, ETPharma

Pfizer (NYSE:PFE) Stock Price Down 1.6% - Should You Sell?

Pfizer signs license deal with Fosun unit for obesity drug

Pfizer strikes deal with YaoPharma for obesity pill

State Street Corp Cuts Holdings in Pfizer Inc. $PFE

Paradigm Capital Management LLC NV Sells 21,686 Shares of Pfizer Inc. $PFE - Markets Daily

Augments Pfizer's efforts to advance investigational medicin

Pfizer Inc. $PFE Shares Sold by Gabelli Funds LLC

Pfizer adds heft to obesity pipeline in $2B Yaopharma deal | BioWorld

2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs

The Dangers of Denying All Vaccine-Related Deaths - The Atlantic

SVB Wealth LLC Invests $4.07 Million in Pfizer Inc. $PFE

Natixis Has $45.97 Million Stock Holdings in Pfizer Inc. $PFE

Ossiam Boosts Stock Position in Pfizer Inc. $PFE

Gamco Investors INC. ET AL Trims Stock Holdings in Pfizer Inc. $PFE

2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Drugs | Morningstar

Ossiam Purchases 2,349,058 Shares of Pfizer Inc. $PFE - Daily Political

Five years of COVID vaccines: how a breakthrough created a public-heath crisis

Eli Lilly, Pfizer, Johnson secure spots on China's drug catalog, Bloomberg says | Markets Insider

Scott Gottlieb says Hepatitis B vaccine birth dose prevents chronic infection - CBS News

Pfizer presents results from the Phase 3 BASIS study on HYMPAVZI | Markets Insider

Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025 - CBS News

Federated Hermes Inc. Raises Stock Position in Pfizer Inc. $PFE

Brown Advisory Inc. Lowers Holdings in Pfizer Inc. $PFE

Pfizer (NYSE:PFE) Shares Up 1.3% - What's Next? - Stock Observer

Eli Lilly, Pfizer Land on China's First Private Insurance List

Kennedy Capital Management LLC Decreases Holdings in Pfizer Inc. $PFE - Daily Political

Findings from the Phase 3 study were presented at the 67 th

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Pharmaceutical Stocks To Watch Today - December 6th - Markets Daily

Experts fear for US childhood vaccine schedule after hepatitis B guideline change - Yahoo News Canada

Cresset Asset Management LLC Boosts Stake in Pfizer Inc. $PFE

Can Pfizer's Recent Recovery Signal a Long Term Value Opportunity in 2025?

Pfizer Inc. $PFE Holdings Lowered by Panagora Asset Management Inc. - Daily Political

Exclusive | AI giant Anthropic hires ex-Chuck Schumer, Eric Adams staffer amid 'woke' claims | New York Post

Immunotherapy Drugs Research Report 2025: $526.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2034

'DNA contamination in Pfizer': Bombshell testimony 'exposes' COVID-vaccine 'lies' at Senate hearing - The Economic Times Video | ET Now

First long-term study on COVID deaths suggests vaccines safe four years on

Baird Financial Group Inc. Sells 406,942 Shares of Pfizer Inc. $PFE

Pfizer Inc. (PFE): A Bull Case Theory

US Acute Myeloid Leukemia Market Size & Share Forecast 2025-2033 | Taiwan News | Dec. 5, 2025 10:13

Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk